Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05275218 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery

Study acronym: PrevProgAKI
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Sep 2025 → Feb 9, 2026
See other at-risk trials from University Hospital Muenster

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Unknown → Active, Not Recruiting
    • Primary completion pushed from Sep 2025 to Feb 9, 2026
    • Study completion pushed from Dec 2025 to Feb 2027
    • Site details revised
    v6
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Primary completion date: Feb 2025 to Sep 2025
    • Primary endpoint revised
    • Study completion date: May 2025 to Dec 2025
    • Secondary endpoints: 17 to 20
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Mar 2024 to Feb 2025
    • Start date changed from estimate of Nov 2022 to Mar 22, 2023
    • Study completion date: Mar 2025 to May 2025
    • Site details revised
  6. Start date: Apr 2022 to Nov 2022
    • Study sites: 0 to 1
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury. To investigate whether an implementation of a supportive extended care "bundle" in high-risk patients for persistent acute kidney injury (AKI) can reduce the occurrence of persistent surgical AKI. In order to investigate whether the extended KDIGO bundle can prevent persistent AKI in patients with high chemokine ligand 14 (CCL14) as well as in patients with low CCL14, patients will be randomized with stratification by the CCL-value.
Trial Details
NCT Number NCT05275218
Lead Sponsor University Hospital Muenster
Collaborators: Baxter Healthcare Corporation
Conditions
(from sponsor)		 Acute Kidney Injury (Nontraumatic)
Related terms Acute Kidney Injury
Enrollment 480 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov